These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30868950)

  • 21. Antiamoebic activities of flavonoids against pathogenic free-living amoebae, Naegleria fowleri and Acanthamoeba species.
    Lê HG; Võ TC; Kang JM; Nguyễn TH; Hwang BS; Oh YT; Na BK
    Parasites Hosts Dis; 2023 Nov; 61(4):449-454. PubMed ID: 38043540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiparasitic Activity of Auranofin against Pathogenic Naegleria fowleri.
    Peroutka-Bigus N; Bellaire BH
    J Eukaryot Microbiol; 2019 Jul; 66(4):684-688. PubMed ID: 30520183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future Priorities in Tackling Infections Due to Brain-Eating Amoebae.
    Khan NA; Anwar A; Siddiqui R
    ACS Chem Neurosci; 2017 Nov; 8(11):2355. PubMed ID: 28933530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatal balamuthosis in a Siberian tiger and a literature review of detection options for free-living amoebic infections in animals.
    Niedringhaus KD; Gordon M; Yabsley MJ; Gai J; Uzal FA; Woolard KD
    J Vet Diagn Invest; 2023 May; 35(3):311-316. PubMed ID: 36908206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human infections caused by free-living amoebae.
    Król-Turmińska K; Olender A
    Ann Agric Environ Med; 2017 May; 24(2):254-260. PubMed ID: 28664704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Amoebic Meningoencephalitis: Potential Application of Ionic Liquids Against Brain-Eating Amoebae?
    Siddiqui R; Abouleish MY; Khamis M; Ibrahim T; Khan NA
    Acta Parasitol; 2022 Jun; 67(2):1032-1034. PubMed ID: 35294972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system infections caused by pathogenic free-living amoebae: An Indian perspective.
    Raju R; Khurana S; Mahadevan A; John DV
    Trop Biomed; 2022 Jun; 39(2):265-280. PubMed ID: 35838101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenic free-living amoebae.
    Im KI
    Kisaengchunghak Chapchi; 1990 Dec; 28 Suppl():29-39. PubMed ID: 2133420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae.
    Taravaud A; Fechtali-Moute Z; Loiseau PM; Pomel S
    Clin Transl Sci; 2021 May; 14(3):791-805. PubMed ID: 33650319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flucofuron as a Promising Therapeutic Agent against Brain-Eating Amoeba.
    Chao-Pellicer J; Arberas-Jiménez I; Sifaoui I; Piñero JE; Lorenzo-Morales J
    ACS Infect Dis; 2024 Jun; 10(6):2063-2073. PubMed ID: 38757533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis.
    Qvarnstrom Y; da Silva AJ; Schuster FL; Gelman BB; Visvesvara GS
    J Infect Dis; 2009 Apr; 199(8):1139-42. PubMed ID: 19302010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunistic amoebae: challenges in prophylaxis and treatment.
    Schuster FL; Visvesvara GS
    Drug Resist Updat; 2004 Feb; 7(1):41-51. PubMed ID: 15072770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lectins as virulence factors in
    Guzmán-Téllez P; Martínez-Castillo M; Flores-Huerta N; Rosales-Morgan G; Pacheco-Yépez J; la Garza M; Serrano-Luna J; Shibayama M
    Future Microbiol; 2020 Jul; 15():919-936. PubMed ID: 32716210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis.
    Huang ZH; Ferrante A; Carter RF
    J Infect Dis; 1999 May; 179(5):1305-8. PubMed ID: 10191243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naegleria fowleri: contact-dependent secretion of electrondense granules (EDG).
    Chávez-Munguía B; Villatoro LS; Omaña-Molina M; Rodríguez-Monroy MA; Segovia-Gamboa N; Martínez-Palomo A
    Exp Parasitol; 2014 Jul; 142():1-6. PubMed ID: 24721258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aryl Quinazolinone Derivatives as Novel Therapeutic Agents against Brain-Eating Amoebae.
    Mungroo MR; Shahbaz MS; Anwar A; Saad SM; Khan KM; Khan NA; Siddiqui R
    ACS Chem Neurosci; 2020 Aug; 11(16):2438-2449. PubMed ID: 31961126
    [No Abstract]   [Full Text] [Related]  

  • 37. [Human pathology caused by free-living amoebae].
    Scaglia M
    Ann Ist Super Sanita; 1997; 33(4):551-66. PubMed ID: 9616966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals.
    Schuster FL; Visvesvara GS
    Int J Parasitol; 2004 Aug; 34(9):1001-27. PubMed ID: 15313128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting CNS Related Protist Pathogens: Calcium Ion Dependency in the Brain-Eating Amoebae.
    Baig AM; Khaleeq A; Nazim F
    ACS Chem Neurosci; 2020 Aug; 11(16):2385-2387. PubMed ID: 31840980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azole and 5-nitroimidazole based nanoformulations are potential antiamoebic drug candidates against brain-eating amoebae.
    Akbar N; Hussain K; Khalid M; Siddiqui R; Shah MR; Khan NA
    J Appl Microbiol; 2023 Apr; 134(4):. PubMed ID: 37024269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.